|
|
Volumn 5, Issue 2, 2008, Pages 55-63
|
|
Pathogenesis and management of lipoatrophy
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
2,4 THIAZOLIDINEDIONE DERIVATIVE;
ABACAVIR;
ANTIRETROVIRUS AGENT;
DIDANOSINE;
EFAVIRENZ;
GLITAZONE DERIVATIVE;
LAMIVUDINE;
LOPINAVIR PLUS RITONAVIR;
METFORMIN;
MITOCHONDRIAL DNA;
PIOGLITAZONE;
PLACEBO;
PRAVASTATIN;
PROTEINASE INHIBITOR;
RNA DIRECTED DNA POLYMERASE INHIBITOR;
ROSIGLITAZONE;
STATIN;
STAVUDINE;
TENOFOVIR;
THYMIDINE;
URIDINE;
ZALCITABINE;
ZIDOVUDINE;
ADIPOCYTE;
APOPTOSIS;
CELL DIFFERENTIATION;
CLINICAL TRIAL;
DRUG DOSE REDUCTION;
DRUG SUBSTITUTION;
ELECTRON MICROSCOPY;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
LIPID STORAGE;
LIPOATROPHY;
MITOCHONDRIAL TOXICITY;
MORBIDITY;
PATHOGENESIS;
PREVALENCE;
REVIEW;
STATISTICAL SIGNIFICANCE;
ADIPOSE TISSUE;
ANTI-HIV AGENTS;
HIV PROTEASE INHIBITORS;
HIV-ASSOCIATED LIPODYSTROPHY SYNDROME;
HUMANS;
MALE;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
REVERSE TRANSCRIPTASE INHIBITORS;
THIAZOLIDINEDIONES;
URIDINE;
|
|
EID: 43249094705
PISSN: 15483568
EISSN: 15483576
Source Type: Journal
DOI: 10.1007/s11904-008-0010-8 Document Type: Review |
|
Times cited : (4)
|
|
References (50)
|
